KPC Pharmaceuticals Inc (600422) - Net Assets

Latest as of September 2025: CN¥6.86 Billion CNY ≈ $1.00 Billion USD

Based on the latest financial reports, KPC Pharmaceuticals Inc (600422) has net assets worth CN¥6.86 Billion CNY (≈ $1.00 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥12.01 Billion ≈ $1.76 Billion USD) and total liabilities (CN¥5.15 Billion ≈ $753.67 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check KPC Pharmaceuticals Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥6.86 Billion
% of Total Assets	57.1%
Annual Growth Rate	15.68%
5-Year Change	46.57%
10-Year Change	102.23%
Growth Volatility	56.64

KPC Pharmaceuticals Inc - Net Assets Trend (1997–2024)

This chart illustrates how KPC Pharmaceuticals Inc's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of KPC Pharmaceuticals Inc for the complete picture of this company's asset base.

Annual Net Assets for KPC Pharmaceuticals Inc (1997–2024)

The table below shows the annual net assets of KPC Pharmaceuticals Inc from 1997 to 2024. For live valuation and market cap data, see 600422 stock market capitalisation.

Year	Net Assets	Change
2024-12-31	CN¥6.75 Billion ≈ $987.19 Million	+23.18%
2023-12-31	CN¥5.48 Billion ≈ $801.39 Million	+6.50%
2022-12-31	CN¥5.14 Billion ≈ $752.51 Million	+4.09%
2021-12-31	CN¥4.94 Billion ≈ $722.92 Million	+7.34%
2020-12-31	CN¥4.60 Billion ≈ $673.51 Million	+6.20%
2019-12-31	CN¥4.33 Billion ≈ $634.22 Million	+9.77%
2018-12-31	CN¥3.95 Billion ≈ $577.79 Million	+4.63%
2017-12-31	CN¥3.77 Billion ≈ $552.21 Million	+4.48%
2016-12-31	CN¥3.61 Billion ≈ $528.55 Million	+8.28%
2015-12-31	CN¥3.34 Billion ≈ $488.14 Million	+62.75%
2014-12-31	CN¥2.05 Billion ≈ $299.93 Million	+9.07%
2013-12-31	CN¥1.88 Billion ≈ $274.98 Million	+77.83%
2012-12-31	CN¥1.06 Billion ≈ $154.63 Million	+15.17%
2011-12-31	CN¥917.52 Million ≈ $134.26 Million	+11.87%
2010-12-31	CN¥820.15 Million ≈ $120.01 Million	+11.08%
2009-12-31	CN¥738.35 Million ≈ $108.04 Million	+10.12%
2008-12-31	CN¥670.50 Million ≈ $98.12 Million	+5.56%
2007-12-31	CN¥635.17 Million ≈ $92.94 Million	+8.79%
2006-12-31	CN¥583.86 Million ≈ $85.44 Million	-0.71%
2005-12-31	CN¥588.02 Million ≈ $86.05 Million	-18.69%
2004-12-31	CN¥723.20 Million ≈ $105.83 Million	+9.58%
2003-12-31	CN¥659.95 Million ≈ $96.57 Million	+15.54%
2002-12-31	CN¥571.17 Million ≈ $83.58 Million	+2.04%
2001-12-31	CN¥559.74 Million ≈ $81.91 Million	+0.38%
2000-12-31	CN¥557.64 Million ≈ $81.60 Million	+295.69%
1999-12-31	CN¥140.93 Million ≈ $20.62 Million	+0.39%
1998-12-31	CN¥140.38 Million ≈ $20.54 Million	+6.27%
1997-12-31	CN¥132.10 Million ≈ $19.33 Million	--

Equity Component Analysis

This analysis shows how different components contribute to KPC Pharmaceuticals Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 361112710865.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥3.60 Billion	68.56%
Common Stock	CN¥756.98 Million	14.41%
Other Components	CN¥894.91 Million	17.03%
Total Equity	CN¥5.25 Billion	100.00%

KPC Pharmaceuticals Inc Competitors by Market Cap

The table below lists competitors of KPC Pharmaceuticals Inc ranked by their market capitalization.

Company	Market Cap
Sarawak Oil Palms Bhd KLSE:5126	$1.05 Billion
Goldman Sachs BDC Inc NYSE:GSBD	$1.05 Billion
Geron Corporation NASDAQ:GERN	$1.05 Billion
Qingdao Port International Co. Ltd F:0QP	$1.05 Billion
GSP Automotive Group Wenzhou Co Ltd SHG:605088	$1.05 Billion
Vertex NASDAQ:VERX	$1.05 Billion
Inversiones Aguas Metropolitanas SA SN:IAM	$1.05 Billion
LegalZoom.com Inc NASDAQ:LZ	$1.05 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in KPC Pharmaceuticals Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 5,297,444,082 to 5,253,648,545, a change of -43,795,537 (-0.8%).
Net income of 648,081,345 contributed positively to equity growth.
Dividend payments of 172,544,936 reduced retained earnings.
Share repurchases of 2,208,928 reduced equity.
Other factors decreased equity by 517,123,018.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥648.08 Million	+12.34%
Dividends Paid	CN¥172.54 Million	-3.28%
Share Repurchases	CN¥2.21 Million	-0.04%
Other Changes	CN¥-517.12 Million	-9.84%
Total Change	CN¥-	-0.83%

Book Value vs Market Value Analysis

This analysis compares KPC Pharmaceuticals Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.36x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 68.93x to 1.36x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1997-12-31	CN¥0.14	CN¥9.50	x
1998-12-31	CN¥0.14	CN¥9.50	x
1999-12-31	CN¥0.16	CN¥9.50	x
2000-12-31	CN¥0.81	CN¥9.50	x
2001-12-31	CN¥0.83	CN¥9.50	x
2002-12-31	CN¥0.60	CN¥9.50	x
2003-12-31	CN¥0.68	CN¥9.50	x
2004-12-31	CN¥0.75	CN¥9.50	x
2005-12-31	CN¥0.82	CN¥9.50	x
2006-12-31	CN¥0.83	CN¥9.50	x
2007-12-31	CN¥0.91	CN¥9.50	x
2008-12-31	CN¥0.97	CN¥9.50	x
2009-12-31	CN¥1.06	CN¥9.50	x
2010-12-31	CN¥1.17	CN¥9.50	x
2011-12-31	CN¥1.30	CN¥9.50	x
2012-12-31	CN¥1.49	CN¥9.50	x
2013-12-31	CN¥2.70	CN¥9.50	x
2014-12-31	CN¥2.44	CN¥9.50	x
2015-12-31	CN¥4.20	CN¥9.50	x
2016-12-31	CN¥4.51	CN¥9.50	x
2017-12-31	CN¥4.67	CN¥9.50	x
2018-12-31	CN¥4.97	CN¥9.50	x
2019-12-31	CN¥5.51	CN¥9.50	x
2020-12-31	CN¥5.86	CN¥9.50	x
2021-12-31	CN¥6.31	CN¥9.50	x
2022-12-31	CN¥6.63	CN¥9.50	x
2023-12-31	CN¥6.99	CN¥9.50	x
2024-12-31	CN¥6.97	CN¥9.50	x

Capital Efficiency Dashboard

This dashboard shows how efficiently KPC Pharmaceuticals Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 12.34%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.71%
• Asset Turnover: 0.67x
• Equity Multiplier: 2.40x
Recent ROE (12.34%) is above the historical average (10.67%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1997	12.72%	4.05%	0.89x	3.51x	CN¥2.36 Million
1998	27.01%	6.09%	0.97x	4.55x	CN¥15.17 Million
1999	24.26%	5.26%	1.04x	4.42x	CN¥14.05 Million
2000	7.60%	7.60%	0.64x	1.56x	CN¥-12.31 Million
2001	7.39%	7.85%	0.64x	1.47x	CN¥-13.56 Million
2002	8.40%	8.83%	0.66x	1.44x	CN¥-8.50 Million
2003	11.73%	10.58%	0.70x	1.58x	CN¥10.38 Million
2004	9.54%	9.97%	0.55x	1.75x	CN¥-3.06 Million
2005	-8.60%	-3.69%	0.98x	2.39x	CN¥-96.38 Million
2006	0.51%	0.23%	1.02x	2.15x	CN¥-49.78 Million
2007	5.06%	2.25%	1.08x	2.07x	CN¥-28.38 Million
2008	5.30%	2.45%	1.13x	1.91x	CN¥-28.54 Million
2009	8.76%	4.06%	1.15x	1.87x	CN¥-8.26 Million
2010	11.64%	4.71%	1.28x	1.93x	CN¥12.05 Million
2011	15.90%	5.38%	1.48x	1.99x	CN¥48.31 Million
2012	19.36%	6.03%	1.40x	2.29x	CN¥87.88 Million
2013	13.18%	6.46%	1.24x	1.64x	CN¥55.82 Million
2014	15.01%	6.69%	1.43x	1.57x	CN¥96.41 Million
2015	12.71%	8.56%	0.99x	1.49x	CN¥89.67 Million
2016	11.45%	7.98%	0.94x	1.52x	CN¥51.50 Million
2017	9.00%	5.64%	0.92x	1.73x	CN¥-36.49 Million
2018	8.78%	4.72%	1.03x	1.80x	CN¥-46.52 Million
2019	10.83%	5.59%	1.09x	1.77x	CN¥34.69 Million
2020	10.26%	5.92%	0.95x	1.82x	CN¥11.79 Million
2021	10.61%	6.15%	0.93x	1.86x	CN¥29.33 Million
2022	7.69%	4.63%	0.88x	1.89x	CN¥-115.12 Million
2023	10.21%	6.41%	0.88x	1.81x	CN¥10.97 Million
2024	12.34%	7.71%	0.67x	2.40x	CN¥122.72 Million

Industry Comparison

This section compares KPC Pharmaceuticals Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $4,208,953,488
Average return on equity (ROE) among peers: 9.27%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
KPC Pharmaceuticals Inc (600422)	CN¥6.86 Billion	12.72%	0.75x	$1.05 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$7.31 Billion	1.28%	4.15x	$1.22 Billion
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$591.07 Million	1.62%	0.52x	$438.59 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$727.05 Million	11.51%	0.20x	$5.18 Billion
Livzon Pharmaceutical Group Inc (000513)	$275.56 Million	21.50%	1.16x	$2.81 Billion
Wedge Industrial Co Ltd (000534)	$552.92 Million	0.39%	0.01x	$2.95 Billion
Yunnan Baiyao Group Co Ltd (000538)	$1.15 Billion	23.74%	0.91x	$13.85 Billion
Hainan Haiyao Co Ltd (000566)	$292.94 Million	7.42%	0.73x	$949.23 Million
Tus Pharmaceutical Group Co Ltd (000590)	$141.91 Million	11.01%	0.32x	$391.07 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$4.71 Billion	7.43%	1.93x	$1.03 Billion
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$26.34 Billion	6.76%	0.18x	$3.30 Billion

About KPC Pharmaceuticals Inc

SHG:600422 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.05 Billion

CN¥7.19 Billion CNY

Market Cap Rank

#8890 Global

#2351 in China

Share Price

CN¥9.50

Change (1 day)

+0.00%

52-Week Range

CN¥9.49 - CN¥16.14

All Time High

CN¥24.62